SNAI2/FTH1P3/miR-218-5p正反循环促进结肠直肠癌的转移
Hong Deng1, Qiang Zhang1, Zhengfei Zhao1
1Department of General Surgery (Gastrointestinal Surgery), The Affiliated Hospital of Southwest Medical University, Taiping Rd. No 25, Luzhou, 646000, China.
Biochemical genetics
|October 26, 2023
概括
这项研究揭示了涉及SNAI2,FTH1P3和miR-218-5p的积极反循环,该循环驱动着结直肠癌 (CRC) 转移. 了解这种机制是针对CRC进展的关键.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 结肠直肠癌 (CRC) 转移是癌症死亡的主要原因.
- 识别导致CRC转移的分子机制对于开发有效治疗方法至关重要.
研究的目的:
- 阐明非编码RNA调节在结直肠癌 (CRC) 转移中的作用.
- 研究涉及FTH1P3在CRC进展中的分子机制.
主要方法:
- 在TCGA-COAD患者队列和CRC细胞系中分析FTH1P3表达.
- 使用JASPR和q-ChIP测试验证FTH1P3转录因子和标的验证.
- 细胞迁移和入侵的评估,使用划痕和穿孔测试.
主要成果:
- FTH1P3在CRC中高度表达,并通过调节上皮质-介质细胞过渡 (EMT) 来促进细胞迁移和入侵.
- SNAI2通过转录激活FTH1P3,两者都受到miR-218-5p的向和抑制.
- 在SNAI2,FTH1P3和miR-218-5p之间的正反循环调节CRC转移.
结论:
- SNAI2/FTH1P3/miR-218-5p轴代表了结直肠癌转移中的新型调节机制.
- 针对这种反循环可能提供一种治疗策略,以抑制CRC进展.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Canonical Wnt Signaling Pathway
8.8K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.8K
Non-Canonical Wnt Signaling Pathways
7.3K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K


